Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Earnings Call

Mukka Proteins Earnings Call: Key Takeaways

Mukka Proteins reported strong FY26 performance with 44% revenue growth reaching ₹1,449.5 Cr. The company is pivoting from a fishmeal producer to an integrated animal protein and sustainability platform.

Why this was an Alfa AlertNot a filter event. Results are strong but no specific prior guidance comparison was provided to verify a beat.
Highlights
Revenue growth44% YoY in FY26 to ₹1,449.5 Cr.
MarginsFY26 EBITDA margin at 10.0% vs 11.0% in FY25.
Order bookSecured ₹474.89 Cr legacy leachate treatment order from BSWML.
Demand visibilityStrong; aquaculture demand growing at 5% CAGR (2024-2030).
Management confidenceHigh; targeting 2x growth in 4 years.

Growth

FY26 Revenue grew 44% YoY to ₹1,449.5 Cr; PAT increased 18.7% YoY to ₹57.1 Cr.

Outlook

Targeting ₹3,000+ Cr revenue by FY30; expanding Oman facility (21,249 sq. mt) and entering Sri Lanka.

Risks

Fishmeal shortages expected from 2028; climate change and El Niño disrupting supply; price volatility.

Source

Earnings Call filed with BSE, NSE: MUKKA. Summary written with AI assistance from the document.

Read the document ↗

Mukka Proteins Ltd: key numbers

Share price
₹27.40
Market cap
₹822.0 Cr
Revenue (annual)
₹1,449 Cr
Net profit (annual)
₹52.06 Cr
P/E (TTM)
11.9×Sector 29.0×
Promoter holding
73.33%+0.00% QoQ
FII holding
1.73%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Mukka Proteins Ltd

All →
22:45 IST BSE
Management Change

Mukka Proteins Management Change

Mukka Proteins Limited announced the re-appointment of six directors to its board, including independent and executive members, each for a five-year term.

22:36 IST NSE
Annual General Meeting

Mukka Proteins Annual General Meeting

Mukka Proteins Limited held its 16th Annual General Meeting on September 10, 2026. The meeting covered financial adoption, director re-appointments, and other routine business.

10:24 IST BSE
Capital Structure Change

Mukka Proteins Capital Structure Change

Mukka Proteins allot 2 Crore convertible warrants to 15 non-promoter investors at Rs. 23.50, raising Rs. 47 Crore. Warrants convert to one equity share in 18 months.

Value
₹47.00 Cr
17:31 IST BSE
Regulatory Approval

Mukka Proteins Regulatory Approval

Mukka Proteins received an 'EU - Inputs Attestation' from ECOCERT S.A.S. for its 'Eco Sphere Organic Fertilizer', validating its suitability for use in organic farming.

Execution
Valid from September 4, 2026, until March 31, 2028
17:23 IST NSE
Business Update

Mukka Proteins Business Update

Mukka Proteins received an EU-Inputs Attestation from ECOCERT S.A.S., France, for its Eco Sphere Organic Fertilizer. This confirms suitability for organic farming, enhancing product marketability.